Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer have?
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer has 1,084 citations in the OpenAlex counts ScholarIQ stores.
When was Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer published?
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer has 2014 year in the ScholarIQ index.
What is the open-access status of Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer?
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer?
The DOI for Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer is on the source record.
What is the PMID of Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer?
The PMID for Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer is on the source record.
What is the OpenAlex record for Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer?
The OpenAlex for Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer is on the source record.